Inside the Global Relay Race to Deliver Moly-99

Moly-99, the radioisotope that is a cancer-detecting necessity, but it decays within days and isn’t made in North America.

But in Janesville, Wisconsin, Shine Medical Technologies is building a $100 million plant that could manufacture up to 50,000 does of imaging agent a week. If this plant in Wisconsin is built, that would make it the first construction project to pass through the labyrinthine nuclear regulatory approval process since 1985.

To read more please visit: https://www.nytimes.com/2018/01/12/business/moly-99-radioactive-isotope-wisconsin.html?_r=0

Source: New York Times